GSTM3 and larynx cancer: For head and neck cancer, in a recent study, an increase in larynx cancer risk associated with GSTM3 AA genotype was suggested [14], similarly, Chatzimichalis et al [9] found that the presence of the GSTM3 B allele appears to be associated with a reduced risk of laryngeal SCC in a Greek population.